Top 5 - yesterday

Top 5 - last week

Top 5 - last month

NL: Establishment of research center for cannabis

Delphy, along with well-known partners in the horticulture industry, has established a research center that focuses on growing medical cannabis called the Medical Cannabis Platform for Innovation and Research (MCPIR). The purpose of this five-year initiative is to investigate the most optimal cultivation methods for medicinal cannabis and create a blueprint for further professionalizing the cultivation process. According to Delphy, what makes this project unique is that clients can obtain reliable information from a single platform, which was developed in a market-oriented research facility, making it a one-stop shop for licensed producers.

The companies involved in MCPIR offer technical expertise, including cultivation consultancy, lighting strategies, climate control, fertilization, substrate, and natural pest and disease control. The platform offers two levels of participation – Founding Partner or Member – which provides access to facilities, expertise, and promotion. In addition to developing a cultivation blueprint, MCPIR also organizes events and training courses to share knowledge with stakeholders and other interested parties and participates in major international exhibitions.

The founding partners of MCPIR are Philips Horticulture LED Solutions by Signify, Koppert B.V., Paradise Seeds, Priva, Mills Nutrients & Substrates, and Delphy B.V.

The participating members are Brightlabs,, Can Filters, and Van Vliet / Newwen.

For more information or for inquiries on how to participate in this platform, contact Jeroen van Buren, project coordinator of MCPIR: Mobile: +31 (0)6 51 59 14 30, Email:  

For more information:


Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.